Kayukawa; Yoko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kayukawa; Yoko.The latest application filed is for "anti-cdh3 humanized antibody, drug conjugate thereof, and use thereof".

Company Profile

0.8.8

Kayukawa; Yoko - Tokyo N/A JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Drug conjugate comprising anti-CDH3 (P-cadherin) antibody Grant 9,764,041 - Ishii , et al. September 19, 2	2017-09-19
Anti-CDH3 humanized antibody, drug conjugate thereof, and use thereof Grant 9,644,028 - Ishii , et al. May 9, 2	2017-05-09
Anti-cdh3 Humanized Antibody, Drug Conjugate Thereof, And Use Thereof App 20160152703 - ISHII; Keisuke ; et al.	2016-06-02
Drug Conjugate Comprising Anti-cdh3 (p-cadherin) Antibody App 20160058883 - ISHII; Keisuke ; et al.	2016-03-03
Anti-human P-cadherin (CDH3) recombinant antibody Grant 9,127,061 - Zhang , et al. September 8, 2	2015-09-08
Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo Grant 9,017,683 - Aburatani , et al. April 28, 2	2015-04-28
Anti-human P-cadherin (cdh3) Recombinant Antibody App 20140221620 - Zhang; Lilin ; et al.	2014-08-07
Highly Effective Anti-cadherin Antibody For Induction Of Antibody-dependent Cellular Cytotoxicity In Vivo App 20130243771 - ABURATANI; Hiroyuki ; et al.	2013-09-19
Highly Effective Anti-cadherin Antibody For Induction Of Antibody-dependent Cellular Cytotoxicity In Vivo App 20130245232 - ABURATANI; Hiroyuki ; et al.	2013-09-19
Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo Grant 8,455,249 - Aburatani , et al. June 4, 2	2013-06-04
Anti-cadherin Antibody App 20120136140 - Aburatani; Hiroyuki ; et al.	2012-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.